Joseph Vazzano
2017 - AVENUE THERAPEUTICS
In 2017, Joseph Vazzano earned a total compensation of $326.5K as Vice President of Finance and Corporate Controller at AVENUE THERAPEUTICS.
Compensation breakdown
| Bonus | $48,630 |
|---|---|
| Salary | $74,756 |
| Stock Awards | $203,100 |
| Total | $326,486 |
Vazzano received $203.1K in stock awards, accounting for 62% of the total pay in 2017.
Vazzano also received $48.6K in bonus and $74.8K in salary.
Rankings
In 2017, Joseph Vazzano's compensation ranked 13,122nd out of 14,666 executives tracked by ExecPay. In other words, Vazzano earned more than 10.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,122 out of 14,666 | 11th |
Division Manufacturing | 5,163 out of 5,768 | 11th |
Major group Chemicals And Allied Products | 1,873 out of 2,074 | 10th |
Industry group Drugs | 1,561 out of 1,730 | 10th |
Industry Pharmaceutical Preparations | 1,206 out of 1,329 | 9th |
Source: SEC filing on April 30, 2018.
Vazzano's colleagues
We found two more compensation records of executives who worked with Joseph Vazzano at AVENUE THERAPEUTICS in 2017.
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019